Cite

HARVARD Citation

    Ghonim, M. et al. (2021). Targeting PARP-1 with metronomic therapy modulates MDSC suppressive function and enhances anti-PD-1 immunotherapy in colon cancer. Journal for immunotherapy of cancer. 9 (1), p. . [Online]. 
  
Back to record